Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Brightstar Associates LLC | 10% Owner | 14 | $78.65M | $0 | 2024-04-22 |
| Pitman Jama | See Remarks | 20 | $0 | $195.1K | 2024-02-16 |
| Martin Daniel C. | Chief Commercial Officer | 27 | $0 | $2.34M | 2024-02-16 |
| Kelly Thomas Patrick | Chief Financial Officer | 97 | $0 | $6.54M | 2024-02-16 |
| Sherman Matthew L | EVP & Chief Medical Officer | 34 | $0 | $445.2K | 2024-02-16 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 5 | $0 | $0 | 2024-02-15 |
| Hoerter Steven L. | President and CEO | 38 | $0 | $1.33M | 2024-02-15 |
| Friedman Franklin Stuart | Director | 12 | $138.8K | $0 | 2024-01-16 |
| Walsh Dennis Leo | Director | 12 | $152.5K | $0 | 2024-01-16 |
| Squarer Ron | Director | 11 | $0 | $0 | 2024-01-16 |
| Allen Patricia L | Director | 24 | $0 | $2.34M | 2024-01-16 |
| Bristol James Arthur | Director | 86 | $0 | $9.09M | 2023-06-21 |
| Martin John Richard | Director | 6 | $0 | $0 | 2023-06-21 |
| Benz Edward J. JR | Director | 10 | $0 | $0 | 2023-06-21 |
| Kelley Susan L. | Director | 8 | $0 | $0 | 2023-06-21 |
| Flynn Daniel Lee | Chief Scientific Officer | 76 | $0 | $29.00M | 2023-06-16 |
| Taylor Michael Douglas | See Remarks | 140 | $0 | $34.93M | 2021-05-03 |
| Morl Christopher John | Chief Business Officer | 38 | $0 | $5.24M | 2020-01-16 |
| New Leaf Venture Associates III, L.P. | 10% Owner | 17 | $6.38M | $12.75M | 2019-08-16 |
| Ross Michael Jay | Director | 2 | $0 | $0 | 2019-06-11 |
| Ruddy Stephen B. | Chief Technical Officer | 2 | $0 | $0 | 2019-01-30 |
| Ratcliffe Liam | Director, 10% Owner | 12 | $6.38M | $0 | 2018-05-17 |
| Rosen Oliver | Chief Medical Officer | 9 | $0 | $0 | 2018-02-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Brightstar Associates LLC | 10% Owner | X Exercise deriv | 2024-04-22 | 2024-04-24 | 48,136 | — | $0 | 0 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | X Exercise | 2024-04-22 | 2024-04-24 | 48,136 | $0.01 | $481 | 23,107,844 | SEC↗ |
| Pitman Jama | SVP, Chief Development Offic | S Sale | 2024-02-16 | 2024-02-20 | 2,267 | $15.62 | $35.4K | 68,031 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2024-02-16 | 2024-02-20 | 2,615 | $15.62 | $40.8K | 108,739 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2024-02-16 | 2024-02-20 | 2,267 | $15.62 | $35.4K | 55,118 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2024-02-16 | 2024-02-20 | 3,010 | $15.62 | $47.0K | 80,350 | SEC↗ |
| Pitman Jama | SVP, Chief Development Offic | A Award deriv | 2024-02-15 | 2024-02-20 | 38,900 | — | $0 | 38,900 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award deriv | 2024-02-15 | 2024-02-20 | 69,100 | — | $0 | 69,100 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award deriv | 2024-02-15 | 2024-02-20 | 38,900 | — | $0 | 38,900 | SEC↗ |
| Dhanak Dashyant | EVP & Chief Scientific Offic | A Award deriv | 2024-02-15 | 2024-02-20 | 69,100 | — | $0 | 69,100 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award deriv | 2024-02-15 | 2024-02-20 | 69,100 | — | $0 | 69,100 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2024-02-15 | 2024-02-20 | 298,100 | — | $0 | 298,100 | SEC↗ |
| Pitman Jama | SVP, Chief Development Offic | A Award | 2024-02-15 | 2024-02-20 | 10,000 | — | $0 | 70,298 | SEC↗ |
| Pitman Jama | SVP, Chief Development Offic | A Award | 2024-02-15 | 2024-02-20 | 9,725 | — | $0 | 60,298 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2024-02-15 | 2024-02-20 | 17,275 | — | $0 | 111,354 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2024-02-15 | 2024-02-20 | 9,725 | — | $0 | 57,385 | SEC↗ |
| Dhanak Dashyant | EVP & Chief Scientific Offic | A Award | 2024-02-15 | 2024-02-20 | 17,275 | — | $0 | 158,175 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2024-02-15 | 2024-02-20 | 17,275 | — | $0 | 83,360 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | X Exercise deriv | 2024-02-07 | 2024-02-09 | 914,001 | — | $0 | 48,136 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | X Exercise | 2024-02-07 | 2024-02-09 | 914,001 | $0.01 | $9.1K | 23,059,708 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2024-01-16 | 2024-01-18 | 1,624 | $14.47 | $23.5K | 47,660 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2024-01-16 | 2024-01-18 | 2,435 | $14.47 | $35.2K | 66,085 | SEC↗ |
| Pitman Jama | SVP, Chief Development Offic | S Sale | 2024-01-16 | 2024-01-18 | 1,624 | $14.47 | $23.5K | 50,573 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2024-01-16 | 2024-01-18 | 2,435 | $14.47 | $35.2K | 94,079 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-12-13 | 2023-12-14 | 2,792 | $15.37 | $42.9K | 96,514 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-12-13 | 2023-12-14 | 1,727 | $15.37 | $26.5K | 49,284 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2023-12-13 | 2023-12-14 | 2,792 | $15.37 | $42.9K | 68,520 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2023-12-13 | 2023-12-14 | 1,662 | $15.37 | $25.5K | 52,197 | SEC↗ |
| Hoerter Steven L. | President and CEO | S Sale | 2023-12-13 | 2023-12-14 | 30,664 | $15.37 | $471.3K | 72,763 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2023-12-12 | 2023-12-14 | 8,244 | — | $0 | 99,306 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2023-12-12 | 2023-12-14 | 5,576 | — | $0 | 51,011 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2023-12-12 | 2023-12-14 | 8,244 | — | $0 | 71,312 | SEC↗ |
| Pitman Jama | See Remarks | A Award | 2023-12-12 | 2023-12-14 | 5,576 | — | $0 | 53,859 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award | 2023-12-12 | 2023-12-14 | 62,500 | — | $0 | 103,427 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-11-30 | 2023-12-01 | 17,801 | $12.57 | $223.8K | 45,435 | SEC↗ |
| Hoerter Steven L. | President and CEO | S Sale | 2023-10-30 | 2023-10-31 | 21,573 | $12.02 | $259.3K | 40,927 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2023-10-30 | 2023-10-31 | 2,316 | $12.02 | $27.8K | 63,068 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-10-30 | 2023-10-31 | 1,407 | $12.02 | $16.9K | 62,884 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2023-10-30 | 2023-10-31 | 1,407 | $12.02 | $16.9K | 48,283 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-10-30 | 2023-10-31 | 2,360 | $12.02 | $28.4K | 90,628 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award | 2023-10-28 | 2023-10-31 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2023-10-28 | 2023-10-31 | 8,244 | — | $0 | 65,384 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2023-10-28 | 2023-10-31 | 5,576 | — | $0 | 64,291 | SEC↗ |
| Pitman Jama | See Remarks | A Award | 2023-10-28 | 2023-10-31 | 5,576 | — | $0 | 49,690 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2023-10-28 | 2023-10-31 | 8,244 | — | $0 | 92,988 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-10-02 | 2023-10-04 | 2,942 | $12.68 | $37.3K | 84,744 | SEC↗ |
| Dhanak Dashyant | EVP & Chief Scientific Offic | A Award deriv | 2023-09-15 | 2023-09-19 | 65,900 | — | $0 | 65,900 | SEC↗ |
| Dhanak Dashyant | EVP & Chief Scientific Offic | A Award | 2023-09-15 | 2023-09-19 | 65,900 | — | $0 | 65,900 | SEC↗ |
| Dhanak Dashyant | EVP & Chief Scientific Offic | A Award | 2023-09-15 | 2023-09-19 | 75,000 | — | $0 | 140,900 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Martin John Richard | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Bristol James Arthur | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2023-06-16 | 2023-06-21 | 1,655 | $14.40 | $23.8K | 57,158 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-06-16 | 2023-06-21 | 1,238 | $14.40 | $17.8K | 58,413 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2023-06-16 | 2023-06-21 | 1,655 | $14.40 | $23.8K | 57,140 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-06-16 | 2023-06-21 | 1,655 | $14.40 | $23.8K | 87,686 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2023-06-16 | 2023-06-21 | 1,238 | $14.40 | $17.8K | 43,812 | SEC↗ |
| Friedman Franklin Stuart | Director | P Buy | 2023-06-08 | 2023-06-12 | 10,000 | $13.88 | $138.8K | 10,000 | SEC↗ |
| Walsh Dennis Leo | Director | P Buy | 2023-05-10 | 2023-05-12 | 11,000 | $13.86 | $152.5K | 11,000 | SEC↗ |
| Hoerter Steven L. | President and CEO | S Sale | 2023-03-21 | 2023-03-23 | 7,500 | $15.57 | $116.8K | 0 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | X Exercise deriv | 2023-02-28 | 2023-03-01 | 2,427,693 | — | $0 | 962,137 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | X Exercise | 2023-02-28 | 2023-03-01 | 2,427,693 | $0.01 | $24.3K | 22,145,707 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2023-02-16 | 2023-02-17 | 1,370 | $15.10 | $20.7K | 58,813 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-02-16 | 2023-02-17 | 971 | $15.10 | $14.7K | 88,145 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2023-02-16 | 2023-02-17 | 1,370 | $15.10 | $20.7K | 58,795 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-02-16 | 2023-02-17 | 1,159 | $15.10 | $17.5K | 58,381 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2023-02-16 | 2023-02-17 | 1,159 | $15.10 | $17.5K | 45,050 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2023-02-15 | 2023-02-16 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 65,900 | — | $0 | 65,900 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 65,900 | — | $0 | 65,900 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 65,900 | — | $0 | 65,900 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 44,600 | — | $0 | 44,600 | SEC↗ |
| Pitman Jama | See Remarks | A Award deriv | 2023-02-15 | 2023-02-17 | 44,600 | — | $0 | 44,600 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award | 2023-02-15 | 2023-02-17 | 16,488 | — | $0 | 60,183 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2023-02-15 | 2023-02-17 | 16,488 | — | $0 | 89,116 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2023-02-15 | 2023-02-17 | 16,488 | — | $0 | 60,165 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2023-02-15 | 2023-02-17 | 11,151 | — | $0 | 59,540 | SEC↗ |
| Pitman Jama | See Remarks | A Award | 2023-02-15 | 2023-02-17 | 11,151 | — | $0 | 46,209 | SEC↗ |
| Hoerter Steven L. | President and CEO | S Sale | 2023-02-14 | 2023-02-16 | 30,045 | $16.00 | $480.7K | 7,500 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | P Buy | 2023-01-24 | 2023-01-24 | 1,666,666 | $18.00 | $30.00M | 19,718,014 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2023-01-17 | 2023-01-19 | 2,403 | $21.24 | $51.0K | 43,677 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2023-01-17 | 2023-01-19 | 1,603 | $21.24 | $34.0K | 48,389 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2023-01-17 | 2023-01-19 | 2,403 | $21.24 | $51.0K | 72,628 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2023-01-17 | 2023-01-19 | 1,603 | $21.24 | $34.0K | 35,058 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2023-01-17 | 2023-01-19 | 2,403 | $21.24 | $51.0K | 43,695 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2022-10-03 | 2022-10-05 | 2,587 | $18.73 | $48.5K | 74,297 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Bristol James Arthur | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Martin John Richard | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2022-06-16 | 2022-06-21 | 1,768 | $10.75 | $19.0K | 46,098 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2022-06-16 | 2022-06-21 | 1,768 | $10.75 | $19.0K | 46,080 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2022-06-16 | 2022-06-21 | 1,311 | $10.75 | $14.1K | 49,521 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2022-06-16 | 2022-06-21 | 1,298 | $10.75 | $14.0K | 36,661 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2022-06-16 | 2022-06-21 | 1,768 | $10.75 | $19.0K | 76,884 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | P Buy deriv | 2022-04-29 | 2022-04-29 | 3,389,830 | $9.99 | $33.86M | 3,389,830 | SEC↗ |
| Brightstar Associates LLC | 10% Owner | P Buy | 2022-04-29 | 2022-04-29 | 1,478,978 | $10.00 | $14.79M | 18,051,348 | SEC↗ |
| Hoerter Steven L. | President and CEO | F Tax w/h | 2022-03-21 | 2022-03-23 | 3,150 | $9.11 | $28.7K | 37,545 | SEC↗ |
| Pitman Jama | See Remarks | S Sale | 2022-02-16 | 2022-02-18 | 1,146 | $9.05 | $10.4K | 37,959 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2022-02-16 | 2022-02-18 | 1,368 | $9.05 | $12.4K | 47,848 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | S Sale | 2022-02-16 | 2022-02-18 | 1,146 | $9.05 | $10.4K | 48,668 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2022-02-16 | 2022-02-18 | 1,366 | $9.05 | $12.4K | 47,866 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2022-02-16 | 2022-02-18 | 984 | $9.05 | $8.9K | 76,790 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2022-01-18 | 2022-01-20 | 415,000 | — | $0 | 415,000 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 82,000 | — | $0 | 82,000 | SEC↗ |
| Pitman Jama | See Remarks | A Award deriv | 2022-01-18 | 2022-01-20 | 54,667 | — | $0 | 54,667 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 82,000 | — | $0 | 82,000 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 54,667 | — | $0 | 54,667 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 82,000 | — | $0 | 82,000 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Bristol James Arthur | Director | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award | 2022-01-18 | 2022-01-20 | 20,500 | — | $0 | 49,232 | SEC↗ |
| Pitman Jama | See Remarks | A Award | 2022-01-18 | 2022-01-20 | 13,667 | — | $0 | 39,105 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2022-01-18 | 2022-01-20 | 20,500 | — | $0 | 77,774 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2022-01-18 | 2022-01-20 | 13,667 | — | $0 | 49,814 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2022-01-18 | 2022-01-20 | 20,500 | — | $0 | 49,216 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award deriv | 2021-12-15 | 2021-12-17 | 62,971 | — | $0 | 62,971 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award deriv | 2021-12-15 | 2021-12-17 | 82,265 | — | $0 | 82,265 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award deriv | 2021-12-15 | 2021-12-17 | 82,265 | — | $0 | 82,265 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2021-12-15 | 2021-12-17 | 270,357 | — | $0 | 270,357 | SEC↗ |
| Pitman Jama | See Remarks | A Award deriv | 2021-12-15 | 2021-12-17 | 62,971 | — | $0 | 62,971 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award deriv | 2021-12-15 | 2021-12-17 | 82,265 | — | $0 | 82,265 | SEC↗ |
| Martin Daniel C. | Chief Commercial Officer | A Award | 2021-12-15 | 2021-12-17 | 8,300 | — | $0 | 36,147 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award | 2021-12-15 | 2021-12-17 | 11,100 | — | $0 | 28,732 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2021-12-15 | 2021-12-17 | 11,100 | — | $0 | 57,274 | SEC↗ |
| Pitman Jama | See Remarks | A Award | 2021-12-15 | 2021-12-17 | 8,300 | — | $0 | 25,438 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2021-12-15 | 2021-12-17 | 11,100 | — | $0 | 28,716 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2021-10-04 | 2021-10-06 | 2,659 | $33.17 | $88.2K | 46,029 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Martin John Richard | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Bristol James Arthur | Director | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-05-03 | 2021-05-05 | 5,646 | — | $0 | 193,752 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-05-03 | 2021-05-05 | 2,354 | — | $0 | 0 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-05-03 | 2021-05-05 | 2,354 | $1.89 | $4.4K | 2,354 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-05-03 | 2021-05-05 | 5,646 | $3.95 | $22.3K | 8,000 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-05-03 | 2021-05-05 | 7,700 | $46.07 | $354.7K | 300 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-05-03 | 2021-05-05 | 300 | $46.75 | $14.0K | 0 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2021-04-20 | 2021-04-21 | 1,700 | — | $0 | 22,150 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-04-20 | 2021-04-21 | 1,700 | $45.60 | $77.5K | 0 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2021-04-20 | 2021-04-21 | 1,700 | $3.95 | $6.7K | 1,700 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2021-04-19 | 2021-04-21 | 5,300 | — | $0 | 23,850 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2021-04-19 | 2021-04-21 | 5,300 | $3.95 | $20.9K | 5,300 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-04-19 | 2021-04-21 | 4,000 | $46.13 | $184.5K | 1,300 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-04-19 | 2021-04-21 | 1,300 | $46.66 | $60.7K | 0 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2021-04-12 | 2021-04-14 | 14,700 | — | $0 | 29,150 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-04-12 | 2021-04-14 | 5,217 | $44.09 | $230.0K | 0 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2021-04-12 | 2021-04-14 | 14,700 | $3.95 | $58.1K | 14,700 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-04-12 | 2021-04-14 | 9,483 | $43.70 | $414.4K | 5,217 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-04-01 | 2021-04-06 | 8,000 | — | $0 | 2,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-04-01 | 2021-04-06 | 906 | $46.72 | $42.3K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-04-01 | 2021-04-06 | 4,994 | $45.69 | $228.2K | 906 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-04-01 | 2021-04-06 | 8,000 | $1.89 | $15.1K | 8,000 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-04-01 | 2021-04-06 | 2,100 | $44.80 | $94.1K | 5,900 | SEC↗ |
| Hoerter Steven L. | President and CEO | F Tax w/h | 2021-03-18 | 2021-03-22 | 700 | $42.39 | $29.7K | 43,145 | SEC↗ |
| Hoerter Steven L. | President and CEO | F Tax w/h | 2021-03-18 | 2021-03-22 | 2,450 | $43.19 | $105.8K | 40,695 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-03-01 | 2021-03-03 | 8,000 | — | $0 | 10,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-03-01 | 2021-03-03 | 1,104 | $44.68 | $49.3K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-03-01 | 2021-03-03 | 6,896 | $43.94 | $303.0K | 1,104 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-03-01 | 2021-03-03 | 8,000 | $1.89 | $15.1K | 8,000 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2021-02-16 | 2021-02-18 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award deriv | 2021-02-16 | 2021-02-18 | 49,900 | — | $0 | 49,900 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award deriv | 2021-02-16 | 2021-02-18 | 49,900 | — | $0 | 49,900 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award deriv | 2021-02-16 | 2021-02-18 | 49,900 | — | $0 | 49,900 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | A Award | 2021-02-16 | 2021-02-18 | 11,100 | — | $0 | 48,386 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | S Sale | 2021-02-16 | 2021-02-18 | 132 | $48.87 | $6.5K | 37,286 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | A Award | 2021-02-16 | 2021-02-18 | 11,100 | — | $0 | 17,632 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | S Sale | 2021-02-16 | 2021-02-18 | 508 | $48.87 | $24.8K | 6,532 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2021-02-16 | 2021-02-18 | 524 | $48.87 | $25.6K | 6,516 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | A Award | 2021-02-16 | 2021-02-18 | 11,100 | — | $0 | 17,616 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-02-01 | 2021-02-03 | 8,000 | — | $0 | 18,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-02-01 | 2021-02-03 | 4,518 | $45.64 | $206.2K | 800 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-02-01 | 2021-02-03 | 8,000 | $1.89 | $15.1K | 8,000 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-02-01 | 2021-02-03 | 800 | $45.96 | $36.8K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-02-01 | 2021-02-03 | 2,682 | $44.34 | $118.9K | 5,318 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise deriv | 2021-01-21 | 2021-01-25 | 1,078 | — | $0 | 395,735 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise | 2021-01-21 | 2021-01-25 | 1,078 | $25.40 | $27.4K | 43,845 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 1,563 | $31.99 | $50.0K | 1,563 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2021-01-15 | 2021-01-20 | 7,000 | — | $0 | 43,850 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 1,563 | $31.99 | $50.0K | 1,563 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2021-01-15 | 2021-01-20 | 1,563 | $31.99 | $50.0K | 1,563 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2021-01-15 | 2021-01-20 | 7,000 | $3.95 | $27.6K | 7,000 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-01-15 | 2021-01-20 | 600 | $51.11 | $30.7K | 0 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2021-01-15 | 2021-01-20 | 6,400 | $50.21 | $321.3K | 600 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2021-01-04 | 2021-01-06 | 19,000 | — | $0 | 26,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-01-04 | 2021-01-06 | 2,794 | $57.37 | $160.3K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-01-04 | 2021-01-06 | 8,517 | $56.73 | $483.2K | 2,794 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2021-01-04 | 2021-01-06 | 7,689 | $55.80 | $429.0K | 11,311 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2021-01-04 | 2021-01-06 | 19,000 | $1.89 | $35.9K | 19,000 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | M Exercise deriv | 2020-12-09 | 2020-12-11 | 207 | — | $0 | 147,096 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | M Exercise | 2020-12-09 | 2020-12-11 | 207 | $34.43 | $7.1K | 37,418 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-12-01 | 2020-12-03 | 19,000 | — | $0 | 45,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-12-01 | 2020-12-03 | 11,309 | $61.16 | $691.7K | 1,211 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-12-01 | 2020-12-03 | 6,480 | $60.23 | $390.3K | 12,520 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-12-01 | 2020-12-03 | 1,011 | $61.87 | $62.6K | 200 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-12-01 | 2020-12-03 | 200 | $62.94 | $12.6K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-12-01 | 2020-12-03 | 19,000 | $1.89 | $35.9K | 19,000 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | M Exercise deriv | 2020-11-16 | 2020-11-18 | 2,697 | — | $0 | 147,303 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | M Exercise | 2020-11-16 | 2020-11-18 | 2,697 | $34.43 | $92.9K | 37,211 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-11-04 | 2020-11-06 | 15,000 | — | $0 | 64,354 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-11-04 | 2020-11-06 | 2,831 | $65.36 | $185.0K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-11-04 | 2020-11-06 | 12,169 | $64.67 | $787.0K | 2,831 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-11-04 | 2020-11-06 | 15,000 | $1.89 | $28.4K | 15,000 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-11-02 | 2020-11-04 | 23,315 | — | $0 | 79,354 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-11-02 | 2020-11-04 | 23,315 | $1.89 | $44.1K | 23,315 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-11-02 | 2020-11-04 | 3,499 | $58.53 | $204.8K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-11-02 | 2020-11-04 | 7,205 | $57.03 | $410.9K | 16,110 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-11-02 | 2020-11-04 | 12,611 | $57.74 | $728.2K | 3,499 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2020-10-09 | 2020-10-13 | 23,541 | — | $0 | 0 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-10-09 | 2020-10-13 | 200 | $55.43 | $11.1K | 0 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-10-09 | 2020-10-13 | 3,971 | $54.53 | $216.5K | 200 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2020-10-09 | 2020-10-13 | 23,541 | $1.89 | $44.5K | 23,541 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-10-09 | 2020-10-13 | 19,370 | $53.35 | $1.03M | 4,171 | SEC↗ |
| Sherman Matthew L | EVP & Chief Medical Officer | F Tax w/h | 2020-10-02 | 2020-10-06 | 2,632 | $51.15 | $134.6K | 34,128 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-10-01 | 2020-10-05 | 20,365 | — | $0 | 102,669 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-10-01 | 2020-10-05 | 104,635 | — | $0 | 0 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-10-01 | 2020-10-05 | 104,635 | $1.89 | $197.8K | 104,635 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-10-01 | 2020-10-05 | 101,114 | $51.52 | $5.21M | 23,886 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-10-01 | 2020-10-05 | 23,886 | $51.98 | $1.24M | 0 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-10-01 | 2020-10-05 | 20,365 | $1.89 | $38.5K | 125,000 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise deriv | 2020-09-14 | 2020-09-16 | 3,000 | — | $0 | 47,008 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2020-09-14 | 2020-09-16 | 3,000 | $50.01 | $150.0K | 7,040 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise | 2020-09-14 | 2020-09-16 | 3,000 | $1.89 | $5.7K | 10,040 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise deriv | 2020-09-10 | 2020-09-10 | 3,000 | — | $0 | 50,008 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2020-09-10 | 2020-09-10 | 3,000 | $47.71 | $143.1K | 7,040 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise | 2020-09-10 | 2020-09-10 | 3,000 | $1.89 | $5.7K | 10,040 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise deriv | 2020-09-08 | 2020-09-10 | 6,000 | — | $0 | 53,008 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2020-09-08 | 2020-09-10 | 800 | $44.69 | $35.8K | 12,240 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2020-09-08 | 2020-09-10 | 3,700 | $45.23 | $167.4K | 8,540 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | S Sale | 2020-09-08 | 2020-09-10 | 1,500 | $46.55 | $69.8K | 7,040 | SEC↗ |
| Kelly Thomas Patrick | Chief Financial Officer | M Exercise | 2020-09-08 | 2020-09-10 | 6,000 | $1.89 | $11.3K | 13,040 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise deriv | 2020-08-20 | 2020-08-24 | 187 | — | $0 | 396,813 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise | 2020-08-20 | 2020-08-24 | 187 | $25.40 | $4.7K | 42,767 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | M Exercise deriv | 2020-08-10 | 2020-08-12 | 9,029 | — | $0 | 0 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | M Exercise | 2020-08-10 | 2020-08-12 | 9,029 | $1.89 | $17.1K | 237,475 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | M Exercise deriv | 2020-07-22 | 2020-07-24 | 130,000 | — | $0 | 9,029 | SEC↗ |
| Flynn Daniel Lee | Chief Scientific Officer | M Exercise | 2020-07-22 | 2020-07-24 | 130,000 | $1.89 | $245.7K | 228,446 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise deriv | 2020-07-20 | 2020-07-22 | 188 | — | $0 | 397,000 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise | 2020-07-20 | 2020-07-22 | 188 | $25.40 | $4.8K | 42,580 | SEC↗ |
| Taylor Michael Douglas | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Friedman Franklin Stuart | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Kelley Susan L. | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Bristol James Arthur | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Walsh Dennis Leo | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2020-07-15 | 2020-07-17 | 723 | $34.58 | $25.0K | 723 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2020-07-09 | 2020-07-13 | 7,217 | — | $0 | 23,541 | SEC↗ |
| Bristol James Arthur | Director | M Exercise deriv | 2020-07-09 | 2020-07-13 | 16,324 | — | $0 | 0 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-07-09 | 2020-07-13 | 12,361 | $54.65 | $675.5K | 11,180 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2020-07-09 | 2020-07-13 | 7,217 | $1.89 | $13.6K | 23,541 | SEC↗ |
| Bristol James Arthur | Director | M Exercise | 2020-07-09 | 2020-07-13 | 16,324 | $1.89 | $30.9K | 16,324 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-07-09 | 2020-07-13 | 301 | $57.02 | $17.2K | 0 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-07-09 | 2020-07-13 | 1,829 | $56.24 | $102.9K | 301 | SEC↗ |
| Bristol James Arthur | Director | S Sale | 2020-07-09 | 2020-07-13 | 9,050 | $55.15 | $499.1K | 2,130 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-07-06 | 2020-07-06 | 27,544 | — | $0 | 104,635 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-06 | 2020-07-06 | 4,283 | $56.55 | $242.2K | 350 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-06 | 2020-07-06 | 6,867 | $55.52 | $381.3K | 4,633 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-06 | 2020-07-06 | 16,044 | $54.69 | $877.4K | 11,500 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-07-06 | 2020-07-06 | 27,544 | $1.89 | $52.1K | 27,544 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-06 | 2020-07-06 | 350 | $57.13 | $20.0K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-07-02 | 2020-07-06 | 48,245 | — | $0 | 132,179 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-02 | 2020-07-06 | 10,345 | $56.01 | $579.4K | 37,900 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-02 | 2020-07-06 | 800 | $57.96 | $46.4K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-02 | 2020-07-06 | 37,100 | $56.85 | $2.11M | 800 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-07-02 | 2020-07-06 | 48,245 | $1.89 | $91.2K | 48,245 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise deriv | 2020-07-01 | 2020-07-06 | 49,211 | — | $0 | 180,424 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-01 | 2020-07-06 | 200 | $60.58 | $12.1K | 0 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-01 | 2020-07-06 | 14,016 | $59.97 | $840.5K | 200 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-01 | 2020-07-06 | 8,632 | $59.02 | $509.5K | 14,216 | SEC↗ |
| Taylor Michael Douglas | Director | S Sale | 2020-07-01 | 2020-07-06 | 26,363 | $58.22 | $1.53M | 22,848 | SEC↗ |
| Taylor Michael Douglas | Director | M Exercise | 2020-07-01 | 2020-07-06 | 49,211 | $1.89 | $93.0K | 49,211 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2020-06-18 | 2020-06-19 | 187 | — | $0 | 397,188 | SEC↗ |
| Hoerter Steven L. | President and CEO | M Exercise | 2020-06-18 | 2020-06-19 | 187 | $25.40 | $4.7K | 42,392 | SEC↗ |
| Benz Edward J. JR | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Allen Patricia L | Director | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |